CD19/CD22 CAR-T cells
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CD19/CD22 CAR-T cells, covering 2024-06-06 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies [Phase 1]